سعر هالونيز 10 مجم/مل نقط بالفم 2026

• Extrapyramidal symptoms are reported frequently, often in the first days of treatment (parkinsonism, akathisia, dystonia including opisthotonos and oculogyric crisis), more frequent and severe at higher doses.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Cardiovascular: tachycardia, hypotension and hypertension; QT prolongation and ventricular arrhythmias including torsades de pointes have also been reported.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Contraindicated in severe toxic central nervous system depression or comatose states from any cause, in hypersensitivity to haloperidol, and in Parkinson's disease.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Boxed warning: elderly patients with dementia-related psychosis treated with antipsychotic drugs are at increased risk of death; haloperidol is not approved for dementia-related psychosis.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Cases of sudden death, QT prolongation and torsades de pointes have been reported in patients receiving haloperidol.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Tardive dyskinesia (potentially irreversible involuntary movements) may develop; risk is believed to increase with treatment duration and cumulative dose, and appears highest in the elderly, especially elderly women.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Neuroleptic malignant syndrome (hyperpyrexia, muscle rigidity, altered mental status, autonomic instability; may include raised CPK, rhabdomyolysis and acute renal failure) has been reported and is potentially fatal.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• LithiumAn encephalopathic syndrome followed by irreversible brain damage has occurred in a few patients given lithium plus haloperidol; a causal relationship is not established, but monitor closely for neurological toxicity and stop promptly if it appears.DailyMed (U.S. National Library of Medicine)

• Neonates exposed to antipsychotics in the third trimester are at risk of extrapyramidal and/or withdrawal symptoms after delivery (agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, feeding disorder). Use in pregnancy only if the potential benefit justifies the potential risk to the fetus.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Infants should not be nursed during drug treatment with haloperidol.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

English text not available for this section.